Transactions
1
Insider / AtriCure, Inc.
JOHNSON B KRISTINE
Director at AtriCure, Inc.
- Company
- AtriCure, Inc.
- Ticker
- ATRC
- First filing on record
- May 20, 2026
- Latest trade on record
- May 18, 2026
- SEC filings
- EDGAR ↗
JOHNSON B KRISTINE, Director at AtriCure, Inc., has disclosed 1 transaction in ATRC since May 20, 2026: 0 purchases (0 open-market buys) and 0 sales, worth about $0 at the reported prices. The latest was filed May 20, 2026, 2 days after the trade.
Open-market buys
0
Sales
0
Avg. disclosure lag
2.0d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months JOHNSON B KRISTINE reported 1 transaction that was neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 1 | 6,144 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 1 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| ATRC | Other A | May 18, 2026 | May 20, 2026 | 2d | 6,144 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| May 20, 2026 | Form 4 | 0001231984-26-000002 | 1 | published | EDGAR ↗ |
Other insiders at AtriCure, Inc.
- Telman Deborah H Director 13 rows
- CARREL MICHAEL H President, CEO, & Director 10 rows
- WEHRWEIN SVEN Director 10 rows
- Doraiswamy Vinayak Chief Scientific Officer 7 rows
- Privitera Salvatore Chief Technical Officer 7 rows
- Dahlquist Karl S. Chief Legal Officer 5 rows
- Noznesky Justin J Chief Mktg & Strategy Officer 5 rows
- Seith Douglas J Chief Operating Officer 5 rows
- Prange Karen Director 3 rows
- WHITE ROBERT S. Director 3 rows
Everyone on file, with contracts and lobbying under the company's name: AtriCure, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 1 | 1 | May 20, 2026 | May 20, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.